Purdue Puts Forth FDA Decisions As Defense To Massachusetts Opioid Suit
Executive Summary
Purdue says Commonwealth is trying to hold it liable for conduct FDA has authorized; citing agency's approval of long-term use of OxyContin for chronic pain, company asks court to dismiss complaint.
You may also be interested in...
Purdue's 'Landmark' Settlement With Oklahoma May Be Harbinger Of MDL Resolution
Company is paying nearly $200m for an Oklahoma State University endowment, $12.5m to abate effects of opioid crisis and $60m for litigation costs.
Former Purdue Chairman Sought To Shadow Opioid Sales Reps, Massachusetts AG Suit Says
Exec was worried Richard Sackler's visits could prompt complaints to FDA's Bad Ad Program; complaint alleges deceptive actions by Purdue execs to boost opioid prescriptions.
Opioid Makers May Have To Pay For Prevention Costs Of 'Man-Made Plague,' Judge Suggests
Bellwether trial set to begin in September after judge says cities may be able to recover damages for cost of governmental services that are the result of defendants' alleged conduct.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: